On July 30, Aehr Test fell 8.03% in regular trading, trading at $64.23/share, with turnover of $64.0029 million. The decline was triggered by the company's late Monday filing of a mixed shelf registration statement with the US Securities and Exchange Commission.

The filing covers the potential sale of common stock, preferred stock, debt securities, depositary shares, warrants, subscription rights, and units, to be offered from time to time in one or more offerings. The broad scope of the registration intensified market fears of equity dilution, particularly given the stock's elevated price levels following a significant rally earlier this month.

Aehr Test had surged over 40% on July 15 after reporting Q4 adjusted EPS of $0.11, which beat the consensus estimate of -$0.01, driven by record quarterly orders tied to AI data center demand. The company's revenue mix has shifted dramatically, with AI-related testing now comprising 71% of annual revenue. The shelf filing at these elevated levels heightened investor concerns that management may capitalize on the recent strength to raise capital, adding selling pressure across the session.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)